Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

被引：0

作者：

Becker, Pamela S. ^{[1
,2
,3
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Natl Med Ctr, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Dept Hematol Malignancies Translat Sci, Beckman Res Inst, Duarte, CA 91010 USA

[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA

来源：

BLOOD CANCER DISCOVERY | 2023年 / 4卷 / 06期

关键词：

OLDER PATIENTS;

D O I：

10.1158/2643-3230.BCD-23-0180

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

High-throughput screens (HTS) have been utilized to assess the efficacy of single drugs against patient tumor samples with the purpose of optimizing precision therapy, but testing the synergy of drug combinations can identify the ideal second drug to add. With novel sophisticated HTS, effective venetoclax combinations can be revealed that provide the cell state, phenotype, and molecular features of the susceptible and resistant cell populations.

引用

页码：437 / 439

页数：3

共 50 条

[1] A Patient-Specific Ex Vivo Screening Platform for Personalized Acute Myeloid Leukemia (AML) Therapy
Azzam, Diana
Volmar, Claude-Henry
Hassan, Al-Ali
Perez, Aymee
Watts, Justin M.
Vargas, Fernando
Elias, Roy
Vega, Francisco
Zelent, Arthur
Cogle, Christopher R.
Wahlestedt, Claes
Swords, Ronan T.
[J]. BLOOD, 2015, 126 (23)
[2] Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
Kuusanmaki, Heikki
Kytola, Sari
Vanttinen, Ida
Ruokoranta, Tanja
Ranta, Amanda
Huuhtanen, Jani
Suvela, Minna
Parsons, Alun
Holopainen, Annasofia
Partanen, Anu
Kuusisto, Milla E. L.
Koskela, Sirpa
Raty, Riikka
Itala-Remes, Maija
Vastrik, Imre
Dufva, Olli
Siitonen, Sanna
Porkka, Kimmo
Wennerberg, Krister
Heckman, Caroline A.
Ettala, Pia
Pyorala, Marja
Rimpilainen, Johanna
Siitonen, Timo
Kontro, Mika
[J]. HAEMATOLOGICA, 2023, 108 (07) : 1768 - 1781
[3] Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Sharma, Amit
Jyotsana, Nidhi
Lai, Courteney K.
Chaturvedi, Anuhar
Gabdoulline, Razif
Goerlich, Kerstin
Murphy, Cecilia
Blanchard, Jan E.
Ganser, Arnold
Brown, Eric
Hassell, John A.
Humphries, R. Keith
Morgan, Michael
Heuser, Michael
[J]. CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 818 - 828
[4] OUTCOME OF PERSONALIZED THERAPY BASED ON HIGH-THROUGHPUT EX VIVO DRUG SCREENING IN PATIENTS WITH RELAPSED, CHEMOREFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Kontro, M.
Pemovska, Tea
Kulesskiy, E.
Edgren, H.
Eldfors, S.
Elonen, E.
Karjalainen, R.
Majumder, M.
Murumagi, A.
Parsons, A.
Aittokallio, T.
Wennerberg, K.
Kallioniemi, O.
Porkka, K.
[J]. HAEMATOLOGICA, 2013, 98 : 19 - 20
[5] TEST OF PERSONALIZED MEDICINE FOR PHARMACOLOGY EX VIVO IN NATIVE ENVIRONMENT FOR ACUTE MYELOID LEUKEMIA
Ballesteros, J.
Martinez Lopez, J.
Martinez, D.
Serrano, J.
Fernandez Abellan, P.
Garcia Boyero, R.
Rodriguez, G.
Herrera Puente, P.
Vidriales Ma, B.
Fernandez Ma, A.
Perez Simon, J. A.
Lavilla Rubira, E.
Bravo De Laguna, Jimenez S.
Gonzalez Fernandez, A.
Alonso De Ozalla, Burgaleta C.
Tormo Diaz, M.
Vives Polo, S.
Alonso Alonso, A.
Simiele, A.
Llamas, P.
Martinez-Sanchez, P.
Hernandez Rivas, J. A.
Sierra Gil, J.
Perez De Oteyza, J.
Montesinos Fernandez, P.
[J]. HAEMATOLOGICA, 2015, 100 : 145 - 145
[6] Niche-like Ex Vivo High Throughput (NEXT) Drug Screening Platform in Acute Myeloid Leukemia
Figueiras, Reinaldo Dal Bello
Pasanisi, Justine
Joudinaud, Romane
Duchmann, Matthieu
Sodaro, Gaetano
Chauvel, Clementine
Vasseur, Loic
Pardieu, Bryann
Ling, Frank
Pacchiardi, Kim
Vaganay, Camille
Faivre, Lionel
Benaksas, Chaima
Preudhomme, Claude
Raffoux, Emmanuel
Clappier, Emmanuelle
Ades, Lionel
Puissant, Alexandre
Itzykson, Raphael
[J]. BLOOD, 2020, 136
[7] Gene expression predicts ex vivo drug sensitivity in acute myeloid leukemia
White, Brian S.
Khan, Suleiman A.
Ammad-ud-din, Muhammad
Potdar, Swapnil
Mason, Mike J.
Tognon, Cristina E.
Druker, Brian J.
Heckman, Caroline A.
Kallioniemi, Olli P.
Kurtz, Stephen E.
Porkka, Kimmo
Tyner, Jeffrey W.
Aittokallio, Tero
Wennerberg, Krister
Guinney, Justin
[J]. CANCER RESEARCH, 2018, 78 (13)
[8] Ex-vivo drug testing predicts chemosensitivity in acute myeloid leukemia
Li, Lihui
Tong, Yin
Straube, Jasmin
Zhao, Jinyan
Gao, Yanting
Bai, Ping
Li, Jia
Wang, Juan
Wang, Hongling
Wang, Xiaorui
Huang, Sheng
Xu, Wen
Song, Xianmin
Li, Li
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (05) : 859 - 870
[9] Venetoclax in acute myeloid leukemia
Bruzzese, Antonella
Martino, Enrica Antonia
Mendicino, Francesco
Lucia, Eugenio
Olivito, Virginia
Neri, Antonino
Morabito, Fortunato
Vigna, Ernesto
Gentile, Massimo
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
[10] Venetoclax in Acute Myeloid Leukemia
Mihaila, Romeo G.
[J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28

← 1 2 3 4 5 →